Cardinal Health Inc.
Cardinal Health Reports Fiscal 2025 Results and Announces Acquisition of Solaris Health
Summary
Cardinal Health, Inc. reported its fiscal 2025 results with relatively flat fourth-quarter revenue of $60.2 billion. Non-GAAP operating earnings increased 19% to $719 million, driven by segment profit increases. The company also announced the acquisition of Solaris Health, a leading urology MSO, to strengthen its multi-specialty growth strategy.
Get alerts for CAH
Be first to know when Cardinal Health Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Official SEC Documents
Advertisement